Strategies for the prevention and treatment of statin-induced myopathy: is there a role for ubiquinone supplementation?

Am J Health Syst Pharm. 2004 Mar 1;61(5):515-9. doi: 10.1093/ajhp/61.5.515.
No abstract available

Publication types

  • Review

MeSH terms

  • Cholesterol, LDL / drug effects
  • Creatine Kinase / blood
  • Drug Monitoring / standards
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperlipidemias / drug therapy*
  • Muscle, Skeletal / drug effects
  • Muscular Diseases / chemically induced*
  • Muscular Diseases / drug therapy
  • Muscular Diseases / physiopathology
  • Muscular Diseases / prevention & control
  • Practice Guidelines as Topic
  • Rhabdomyolysis / chemically induced
  • Rhabdomyolysis / drug therapy
  • Rhabdomyolysis / physiopathology
  • Rhabdomyolysis / prevention & control
  • Ubiquinone / blood
  • Ubiquinone / deficiency
  • Ubiquinone / therapeutic use*

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Ubiquinone
  • Creatine Kinase